Search Results - Massimo Federico

Refine Results
  1. 1

    The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell Project by Monica Bellei, Massimo Federico

    Published in Haematologica (2019-04-01)
    Get full text
    Article


  2. 2

    BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE? by Irene Dogliotti, Massimo Federico

    Published in Haematologica (2025-07-01)
    Get full text
    Article


  3. 3

    Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines by Igor Aurer, Natalia Zing, Massimo Federico

    Published in HemaSphere (2020-08-01)
    Get full text
    Article


  4. 4

    La Cantera: “A Star Is Born” in Hematology by Martin Dreyling, Martina Manni, Massimo Federico

    Published in HemaSphere (2023-04-01)
    Get full text
    Article


  5. 5

    EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN by Massimiliano Salati, Marina Cesaretti, Matteo Macchia, Mufid El Mistiri, Massimo Federico

    Get full text
    Article


  6. 6

    Precision medicine in diffuse large B-cell lymphoma: hitting the target by Joost S. Vermaat, Steven T. Pals, Anas Younes, Martin Dreyling, Massimo Federico, Igor Aurer, John Radford, Marie José Kersten

    Published in Haematologica (2015-08-01)
    Get full text
    Article


  7. 7

    P1181: REAL-LIFE TREATMENT APPROACHES AND THERAPY RESULTS IN THE PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA: POLISH-UKRAINIAN EXPERIENCE by Kateryna Filonenko, Agata Szymańska, Yana Stepanishyna, Nazar Shokun, Tetiana Skrypets, Massimo Federico, Irina Kryachok, Martina Manni, Jan Zaucha

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  8. 8

    Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG) by Igor Aurer, Martin Dreyling, Massimo Federico, Herve Tilly, Kim Linton, Eva Kimby, Martine E. D. Chamuleau, Marie Jose Kersten

    Published in HemaSphere (2020-12-01)
    Get full text
    Article


  9. 9

    EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic by Martin Dreyling, Igor Aurer, Massimo Federico, Mats Jerkeman, Marie Jose Kersten, Kim Linton, Ulrich Mey, Herve Tilly, Christian Buske

    Published in HemaSphere (2021-02-01)
    Get full text
    Article


  10. 10

    Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial... by Stefano Luminari, Sara Galimberti, Annibale Versari, Irene Biasoli, Antonella Anastasia, Chiara Rusconi, Angela Ferrari, Mario Petrini, Martina Manni, Massimo Federico

    Published in Haematologica (2016-02-01)
    Get full text
    Article


  11. 11

    Second malignancies after treatment of diffuse large B-cell non-Hodgkin’s lymphoma: a GISL cohort study by Stefano Sacchi, Luigi Marcheselli, Alessia Bari, Raffaella Marcheselli, Samantha Pozzi, Paolo G. Gobbi, Francesco Angrilli, Maura Brugiatelli, Pellegrino Musto, Massimo Federico

    Published in Haematologica (2008-09-01)
    Get full text
    Article


  12. 12

    Brentuximab vedotin followed by ABVD +/− radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study by Massimo Federico, Stefano Luminari, Cinzia Pellegrini, Francesco Merli, Emanuela Anna Pesce, Stephane Chauvie, Letizia Gandolfi, Isabella Capodanno, Massimiliano Salati, Lisa Argnani, Pier Luigi Zinzani

    Published in Haematologica (2016-04-01)
    Get full text
    Article


  13. 13

    Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study by Elizabeth H. Phillips, Nicholas Counsell, Tim Illidge, Marc Andre, Igor Aurer, Valeria Fiaccadori, Catherine Fortpied, Anouk Neven, Massimo Federico, Sally F. Barrington, John Raemaekers, John Radford

    Published in Blood Advances (2025-05-01)
    Get full text
    Article


  14. 14

    High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy: long-term res... by Angelo Michele Carella, Monica Bellei, Pauline Brice, Christian Gisselbrecht, Giuseppe Visani, Philippe Colombat, Francesco Fabbiano, Amedea Donelli, Stefano Luminari, Pierre Feugier, Peter Browett, Hans Hagberg, Massimo Federico

    Published in Haematologica (2009-01-01)
    Get full text
    Article


  15. 15

    Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituxima... by Tamar Tadmor, Alessia Bari, Stefano Sacchi, Luigi Marcheselli, Eliana Valentina Liardo, Irit Avivi, Noam Benyamini, Dina Attias, Samantha Pozzi, Maria Christina Cox, Luca Baldini, Maura Brugiatelli, Massimo Federico, Aaron Polliack

    Published in Haematologica (2014-01-01)
    Get full text
    Article


  16. 16

    Treatment of Burkitt lymphoma in real-world setting: findings on 104 consecutive cases diagnosed and treated in Kazakhstan over the last decade by Akmaral Jazyltayeva, Nazarii Shokun, Ayazhan Umutbayeva, Luana Conte, Raigul Ramazanova, Vadim Kemaikin, Azat Karabekov, Aidana Shalabay, Aigerim Koshkarbayeva, Nurbergen Kemelbekov, Madina Zhumabay, Fariza Shokubayeva, Yana Stepanihyna, Massimo Federico, Saule Gabbasova

    Published in Annals of Hematology (2026-03-01)
    Get full text
    Article


  17. 17

    High‐dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited‐stage Hodgkin lymphoma progressing/relapsing af... by Gotti Manuel, Yana Stepanishyna, Tetiana Skrypets, Luigi Marcheselli, Caterina Cristinelli, Barbara Botto, Sanne Tonino, Doriane Cavalieri, Alessandro Pulsoni, Martin Hutchings, Mohammad Hammoud, Catherine Fortpied, Luigi Rigacci, Wouter Plattel, Marc André, Massimo Federico

    Published in HemaSphere (2025-04-01)
    Get full text
    Article


  18. 18

    Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients by Marcia Torresan Delamain, Maria Gomes da Silva, Eliana Cristina Martins Miranda, Joana Desterro, Stefano Luminari, Anna Fedina, Francesco Merli, Carlos Sergio Chiattone, Katia Borgia Barbosa Pagnano, Massimo Federico, Carmino Antonio de Souza

    Get full text
    Article


  19. 19

    Peripheral T‐ and natural killer‐cell lymphomas: ESMO‐EHA Clinical Practice Guideline for diagnosis, treatment, and follow‐up by Francesco d'Amore, Massimo Federico, Laurence de Leval, Fredrik Ellin, Olivier Hermine, Won Seog Kim, François Lemonnier, Joost S. P. Vermaat, Gerald Wulf, Christian Buske, Martin Dreyling, Mats Jerkeman, the ESMO and EHA Guidelines Committees

    Published in HemaSphere (2025-05-01)
    Get full text
    Article


  20. 20

    Low Incidence of Cancer Recorded in the Galapagos Archipelago by Stefano Nicolas Chisesi, Massimo Rugge, Giulia Raffaella Galli, Martina Manni, Veronica Mishell Luzuriaga Delgado, Teodoro Chisesi, Juan Carlos Ruiz, Rina Mariuxi Quinto Briones, Luisa Siculella, Stefano Guzzinati, Manuel Zorzi, Massimo Federico, Anna Iannone

    Published in Cancer Reports (2024-12-01)
    Get full text
    Article


Search Tools: